Insider trades
Daniel Newman Mendelson, Director of Champions Oncology CSBR, has filed 25 purchases and 0 sales on the open market. The latest trade was on 25/11/05.
Daniel Newman Mendelson
Director
- Company
- Champions Oncology CSBR
- First filing
- 23/08/17
- Trades
- 29 trades
- Buys / sales
- 25 / 0
- 12-month net buying
- No record
- Last trade
- 25/11/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 24/01/12 | 24/01/16 | 1,000 sh | $6.50 | $6,500 | +0.5% | |
| Open-market buy | 24/01/11 | 24/01/12 | 2,000 sh | $6.27 | $12,540 | +1.0% | |
| Open-market buy | 24/01/10 | 24/01/11 | 2,944 sh | $6.31 | $18,576.64 | +1.5% | |
| Open-market buy | 24/01/09 | 24/01/10 | 3,000 sh | $6.25 | $18,750 | +1.6% | |
| Open-market buy | 24/01/08 | 24/01/09 | 1,000 sh | $6.15 | $6,150 | +0.5% | |
CSBR | Open-market buy | 24/01/04–24/01/05 | 24/01/08 | 5,000 sh2 trades | $6.11avg. | $30,540 | +2.7% |
| Open-market buy | 24/01/03 | 24/01/04 | 500 sh | $5.83 | $2,915 | +0.3% | |
| Open-market buy | 23/12/21 | 23/12/26 | 2,500 sh | $4.92 | $12,300 | +1.4% | |
| Open-market buy | 23/12/20 | 23/12/21 | 2,100 sh | $4.82 | $10,122 | +1.2% | |
| Open-market buy | 23/12/19 | 23/12/20 | 5,000 sh | $4.75 | $23,750 | +2.9% | |
CSBR | Open-market buy | 23/09/27–23/09/29 | 23/10/16 | 10,500 sh3 trades | $6.16avg. | $64,665 | +6.4% |
| Open-market buy | 23/10/11 | 23/10/13 | 5,000 sh | $6.40 | $32,000 | +3.2% | |
| Open-market buy | 23/10/10 | 23/10/11 | 1,100 sh | $6.41 | $7,051 | +0.7% | |
| Open-market buy | 23/10/06 | 23/10/10 | 1,530 sh | $6.48 | $9,914.4 | +1.0% | |
| Open-market buy | 23/10/05 | 23/10/06 | 2,000 sh | $6.47 | $12,940 | +1.3% | |
CSBR | Open-market buy | 23/10/03–23/10/04 | 23/10/04 | 7,500 sh2 trades | $6.37avg. | $47,750 | +5.1% |
| Open-market buy | 23/09/26 | 23/09/27 | 5,000 sh | $5.65 | $28,250 | +3.5% | |
CSBR | Open-market buy | 23/09/19–23/09/22 | 23/09/25 | 17,830 sh4 trades | $5.44avg. | $97,055.18 | +14.5% |